Neurorehabilitation Devices Market to Reach $3.9 Billion by 2027
Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 9. - Influencer Pool: 5339. - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies.
New York, April 01, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Neurorehabilitation Devices Industry" - https://www.reportlinker.com/p05961066/?utm_source=GNW
In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack.
- Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations.
Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.
Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.
Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.
Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations.
Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives.
Abstract:
- Global Neurorehabilitation Devices Market to Reach $3.9 Billion by 2027
- Amid the COVID-19 crisis, the global market for Neurorehabilitation Devices estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$3.9 Billion by 2027, growing at a CAGR of 14.3% over the analysis period 2020-2027. Neurorobotic Systems, one of the segments analyzed in the report, is projected to record a 12.3% CAGR and reach US$1.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Brain Computer Interfaces segment is readjusted to a revised 14.3% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $418.1 Million, While China is Forecast to Grow at 18.6% CAGR
- The Neurorehabilitation Devices market in the U.S. is estimated at US$418.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$874.5 Million by the year 2027 trailing a CAGR of 18.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.2% and 12.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 11.3% CAGR.
- Non-invasive Brain Stimulators Segment to Record 17.6% CAGR
- In the global Non-invasive Brain Stimulators segment, USA, Canada, Japan, China and Europe will drive the 16.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$297.9 Million in the year 2020 will reach a projected size of US$870.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$601.9 Million by the year 2027, while Latin America will expand at a 19.4% CAGR through the analysis period.
- Select Competitors (Total 41 Featured) -
Bioness Inc.
Ectron Ltd.
Ekso Bionics
Helius Medical Technologies
Hocoma AG
Kinestica
Kinova Inc.
Medtronic PLC
Neurostyle Pte Ltd.
Rehab-Robotics Company Limited.
Read the full report: https://www.reportlinker.com/p05961066/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for
Neurorehabilitation Devices by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Neurorehabilitation Devices
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for Neurorehabilitation
Devices by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2012,
2020 & 2027
Table 4: World Current & Future Analysis for Neurorobotic
Systems by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 5: World Historic Review for Neurorobotic Systems by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 6: World 15-Year Perspective for Neurorobotic Systems by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 7: World Current & Future Analysis for Brain Computer
Interfaces by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 8: World Historic Review for Brain Computer Interfaces by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 9: World 15-Year Perspective for Brain Computer
Interfaces by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027
Table 10: World Current & Future Analysis for Non-invasive
Brain Stimulators by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 11: World Historic Review for Non-invasive Brain
Stimulators by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 12: World 15-Year Perspective for Non-invasive Brain
Stimulators by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027
Table 13: World Current & Future Analysis for Wearable Devices
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 14: World Historic Review for Wearable Devices by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 15: World 15-Year Perspective for Wearable Devices by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 16: World Current & Future Analysis for Stroke by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 17: World Historic Review for Stroke by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 18: World 15-Year Perspective for Stroke by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
Table 19: World Current & Future Analysis for Traumatic Brain
Injury by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 20: World Historic Review for Traumatic Brain Injury by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 21: World 15-Year Perspective for Traumatic Brain Injury
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 22: World Current & Future Analysis for Spinal Cord
Injury by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 23: World Historic Review for Spinal Cord Injury by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 24: World 15-Year Perspective for Spinal Cord Injury by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 25: World Current & Future Analysis for Parkinsons by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 26: World Historic Review for Parkinsons by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 27: World 15-Year Perspective for Parkinsons by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 28: World Current & Future Analysis for Cerebral Palsy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 29: World Historic Review for Cerebral Palsy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 30: World 15-Year Perspective for Cerebral Palsy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 31: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 32: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 33: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
Table 34: USA Current & Future Analysis for Neurorehabilitation
Devices by Product - Neurorobotic Systems, Brain Computer
Interfaces, Non-invasive Brain Stimulators and Wearable Devices -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 35: USA Historic Review for Neurorehabilitation Devices
by Product - Neurorobotic Systems, Brain Computer Interfaces,
Non-invasive Brain Stimulators and Wearable Devices Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 36: USA 15-Year Perspective for Neurorehabilitation
Devices by Product - Percentage Breakdown of Value Sales for
Neurorobotic Systems, Brain Computer Interfaces, Non-invasive
Brain Stimulators and Wearable Devices for the Years 2012, 2020 &
2027
Table 37: USA Current & Future Analysis for Neurorehabilitation
Devices by Application - Stroke, Traumatic Brain Injury, Spinal
Cord Injury, Parkinsons, Cerebral Palsy and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 38: USA Historic Review for Neurorehabilitation Devices
by Application - Stroke, Traumatic Brain Injury, Spinal Cord
Injury, Parkinsons, Cerebral Palsy and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 39: USA 15-Year Perspective for Neurorehabilitation
Devices by Application - Percentage Breakdown of Value Sales
for Stroke, Traumatic Brain Injury, Spinal Cord Injury,
Parkinsons, Cerebral Palsy and Other Applications for the Years
2012, 2020 & 2027
CANADA
Table 40: Canada Current & Future Analysis for
Neurorehabilitation Devices by Product - Neurorobotic Systems,
Brain Computer Interfaces, Non-invasive Brain Stimulators and
Wearable Devices - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 41: Canada Historic Review for Neurorehabilitation
Devices by Product - Neurorobotic Systems, Brain Computer
Interfaces, Non-invasive Brain Stimulators and Wearable Devices
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 42: Canada 15-Year Perspective for Neurorehabilitation
Devices by Product - Percentage Breakdown of Value Sales for
Neurorobotic Systems, Brain Computer Interfaces, Non-invasive
Brain Stimulators and Wearable Devices for the Years 2012, 2020 &
2027
Table 43: Canada Current & Future Analysis for
Neurorehabilitation Devices by Application - Stroke, Traumatic
Brain Injury, Spinal Cord Injury, Parkinsons, Cerebral Palsy
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 44: Canada Historic Review for Neurorehabilitation
Devices by Application - Stroke, Traumatic Brain Injury, Spinal
Cord Injury, Parkinsons, Cerebral Palsy and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 45: Canada 15-Year Perspective for Neurorehabilitation
Devices by Application - Percentage Breakdown of Value Sales
for Stroke, Traumatic Brain Injury, Spinal Cord Injury,
Parkinsons, Cerebral Palsy and Other Applications for the Years
2012, 2020 & 2027
JAPAN
Table 46: Japan Current & Future Analysis for
Neurorehabilitation Devices by Product - Neurorobotic Systems,
Brain Computer Interfaces, Non-invasive Brain Stimulators and
Wearable Devices - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 47: Japan Historic Review for Neurorehabilitation Devices
by Product - Neurorobotic Systems, Brain Computer Interfaces,
Non-invasive Brain Stimulators and Wearable Devices Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 48: Japan 15-Year Perspective for Neurorehabilitation
Devices by Product - Percentage Breakdown of Value Sales for
Neurorobotic Systems, Brain Computer Interfaces, Non-invasive
Brain Stimulators and Wearable Devices for the Years 2012, 2020 &
2027
Table 49: Japan Current & Future Analysis for
Neurorehabilitation Devices by Application - Stroke, Traumatic
Brain Injury, Spinal Cord Injury, Parkinsons, Cerebral Palsy
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 50: Japan Historic Review for Neurorehabilitation Devices
by Application - Stroke, Traumatic Brain Injury, Spinal Cord
Injury, Parkinsons, Cerebral Palsy and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 51: Japan 15-Year Perspective for Neurorehabilitation
Devices by Application - Percentage Breakdown of Value Sales
for Stroke, Traumatic Brain Injury, Spinal Cord Injury,
Parkinsons, Cerebral Palsy and Other Applications for the Years
2012, 2020 & 2027
CHINA
Table 52: China Current & Future Analysis for
Neurorehabilitation Devices by Product - Neurorobotic Systems,
Brain Computer Interfaces, Non-invasive Brain Stimulators and
Wearable Devices - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 53: China Historic Review for Neurorehabilitation Devices
by Product - Neurorobotic Systems, Brain Computer Interfaces,
Non-invasive Brain Stimulators and Wearable Devices Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 54: China 15-Year Perspective for Neurorehabilitation
Devices by Product - Percentage Breakdown of Value Sales for
Neurorobotic Systems, Brain Computer Interfaces, Non-invasive
Brain Stimulators and Wearable Devices for the Years 2012, 2020 &
2027
Table 55: China Current & Future Analysis for
Neurorehabilitation Devices by Application - Stroke, Traumatic
Brain Injury, Spinal Cord Injury, Parkinsons, Cerebral Palsy
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 56: China Historic Review for Neurorehabilitation Devices
by Application - Stroke, Traumatic Brain Injury, Spinal Cord
Injury, Parkinsons, Cerebral Palsy and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 57: China 15-Year Perspective for Neurorehabilitation
Devices by Application - Percentage Breakdown of Value Sales
for Stroke, Traumatic Brain Injury, Spinal Cord Injury,
Parkinsons, Cerebral Palsy and Other Applications for the Years
2012, 2020 & 2027
EUROPE
Table 58: Europe Current & Future Analysis for
Neurorehabilitation Devices by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 59: Europe Historic Review for Neurorehabilitation
Devices by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 60: Europe 15-Year Perspective for Neurorehabilitation
Devices by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2012, 2020 & 2027
Table 61: Europe Current & Future Analysis for
Neurorehabilitation Devices by Product - Neurorobotic Systems,
Brain Computer Interfaces, Non-invasive Brain Stimulators and
Wearable Devices - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 62: Europe Historic Review for Neurorehabilitation
Devices by Product - Neurorobotic Systems, Brain Computer
Interfaces, Non-invasive Brain Stimulators and Wearable Devices
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 63: Europe 15-Year Perspective for Neurorehabilitation
Devices by Product - Percentage Breakdown of Value Sales for
Neurorobotic Systems, Brain Computer Interfaces, Non-invasive
Brain Stimulators and Wearable Devices for the Years 2012, 2020 &
2027
Table 64: Europe Current & Future Analysis for
Neurorehabilitation Devices by Application - Stroke, Traumatic
Brain Injury, Spinal Cord Injury, Parkinsons, Cerebral Palsy
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 65: Europe Historic Review for Neurorehabilitation
Devices by Application - Stroke, Traumatic Brain Injury, Spinal
Cord Injury, Parkinsons, Cerebral Palsy and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 66: Europe 15-Year Perspective for Neurorehabilitation
Devices by Application - Percentage Breakdown of Value Sales
for Stroke, Traumatic Brain Injury, Spinal Cord Injury,
Parkinsons, Cerebral Palsy and Other Applications for the Years
2012, 2020 & 2027
FRANCE
Table 67: France Current & Future Analysis for
Neurorehabilitation Devices by Product - Neurorobotic Systems,
Brain Computer Interfaces, Non-invasive Brain Stimulators and
Wearable Devices - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 68: France Historic Review for Neurorehabilitation
Devices by Product - Neurorobotic Systems, Brain Computer
Interfaces, Non-invasive Brain Stimulators and Wearable Devices
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 69: France 15-Year Perspective for Neurorehabilitation
Devices by Product - Percentage Breakdown of Value Sales for
Neurorobotic Systems, Brain Computer Interfaces, Non-invasive
Brain Stimulators and Wearable Devices for the Years 2012, 2020 &
2027
Table 70: France Current & Future Analysis for
Neurorehabilitation Devices by Application - Stroke, Traumatic
Brain Injury, Spinal Cord Injury, Parkinsons, Cerebral Palsy
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 71: France Historic Review for Neurorehabilitation
Devices by Application - Stroke, Traumatic Brain Injury, Spinal
Cord Injury, Parkinsons, Cerebral Palsy and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 72: France 15-Year Perspective for Neurorehabilitation
Devices by Application - Percentage Breakdown of Value Sales
for Stroke, Traumatic Brain Injury, Spinal Cord Injury,
Parkinsons, Cerebral Palsy and Other Applications for the Years
2012, 2020 & 2027
GERMANY
Table 73: Germany Current & Future Analysis for
Neurorehabilitation Devices by Product - Neurorobotic Systems,
Brain Computer Interfaces, Non-invasive Brain Stimulators and
Wearable Devices - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 74: Germany Historic Review for Neurorehabilitation
Devices by Product - Neurorobotic Systems, Brain Computer
Interfaces, Non-invasive Brain Stimulators and Wearable Devices
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 75: Germany 15-Year Perspective for Neurorehabilitation
Devices by Product - Percentage Breakdown of Value Sales for
Neurorobotic Systems, Brain Computer Interfaces, Non-invasive
Brain Stimulators and Wearable Devices for the Years 2012, 2020 &
2027
Table 76: Germany Current & Future Analysis for
Neurorehabilitation Devices by Application - Stroke, Traumatic
Brain Injury, Spinal Cord Injury, Parkinsons, Cerebral Palsy
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 77: Germany Historic Review for Neurorehabilitation
Devices by Application - Stroke, Traumatic Brain Injury, Spinal
Cord Injury, Parkinsons, Cerebral Palsy and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 78: Germany 15-Year Perspective for Neurorehabilitation
Devices by Application - Percentage Breakdown of Value Sales
for Stroke, Traumatic Brain Injury, Spinal Cord Injury,
Parkinsons, Cerebral Palsy and Other Applications for the Years
2012, 2020 & 2027
ITALY
Table 79: Italy Current & Future Analysis for
Neurorehabilitation Devices by Product - Neurorobotic Systems,
Brain Computer Interfaces, Non-invasive Brain Stimulators and
Wearable Devices - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 80: Italy Historic Review for Neurorehabilitation Devices
by Product - Neurorobotic Systems, Brain Computer Interfaces,
Non-invasive Brain Stimulators and Wearable Devices Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 81: Italy 15-Year Perspective for Neurorehabilitation
Devices by Product - Percentage Breakdown of Value Sales for
Neurorobotic Systems, Brain Computer Interfaces, Non-invasive
Brain Stimulators and Wearable Devices for the Years 2012, 2020 &
2027
Table 82: Italy Current & Future Analysis for
Neurorehabilitation Devices by Application - Stroke, Traumatic
Brain Injury, Spinal Cord Injury, Parkinsons, Cerebral Palsy
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 83: Italy Historic Review for Neurorehabilitation Devices
by Application - Stroke, Traumatic Brain Injury, Spinal Cord
Injury, Parkinsons, Cerebral Palsy and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 84: Italy 15-Year Perspective for Neurorehabilitation
Devices by Application - Percentage Breakdown of Value Sales
for Stroke, Traumatic Brain Injury, Spinal Cord Injury,
Parkinsons, Cerebral Palsy and Other Applications for the Years
2012, 2020 & 2027
UNITED KINGDOM
Table 85: UK Current & Future Analysis for Neurorehabilitation
Devices by Product - Neurorobotic Systems, Brain Computer
Interfaces, Non-invasive Brain Stimulators and Wearable Devices -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 86: UK Historic Review for Neurorehabilitation Devices by
Product - Neurorobotic Systems, Brain Computer Interfaces,
Non-invasive Brain Stimulators and Wearable Devices Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 87: UK 15-Year Perspective for Neurorehabilitation
Devices by Product - Percentage Breakdown of Value Sales for
Neurorobotic Systems, Brain Computer Interfaces, Non-invasive
Brain Stimulators and Wearable Devices for the Years 2012, 2020 &
2027
Table 88: UK Current & Future Analysis for Neurorehabilitation
Devices by Application - Stroke, Traumatic Brain Injury, Spinal
Cord Injury, Parkinsons, Cerebral Palsy and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 89: UK Historic Review for Neurorehabilitation Devices by
Application - Stroke, Traumatic Brain Injury, Spinal Cord
Injury, Parkinsons, Cerebral Palsy and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 90: UK 15-Year Perspective for Neurorehabilitation
Devices by Application - Percentage Breakdown of Value Sales
for Stroke, Traumatic Brain Injury, Spinal Cord Injury,
Parkinsons, Cerebral Palsy and Other Applications for the Years
2012, 2020 & 2027
SPAIN
Table 91: Spain Current & Future Analysis for
Neurorehabilitation Devices by Product - Neurorobotic Systems,
Brain Computer Interfaces, Non-invasive Brain Stimulators and
Wearable Devices - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 92: Spain Historic Review for Neurorehabilitation Devices
by Product - Neurorobotic Systems, Brain Computer Interfaces,
Non-invasive Brain Stimulators and Wearable Devices Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 93: Spain 15-Year Perspective for Neurorehabilitation
Devices by Product - Percentage Breakdown of Value Sales for
Neurorobotic Systems, Brain Computer Interfaces, Non-invasive
Brain Stimulators and Wearable Devices for the Years 2012, 2020 &
2027
Table 94: Spain Current & Future Analysis for
Neurorehabilitation Devices by Application - Stroke, Traumatic
Brain Injury, Spinal Cord Injury, Parkinsons, Cerebral Palsy
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 95: Spain Historic Review for Neurorehabilitation Devices
by Application - Stroke, Traumatic Brain Injury, Spinal Cord
Injury, Parkinsons, Cerebral Palsy and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 96: Spain 15-Year Perspective for Neurorehabilitation
Devices by Application - Percentage Breakdown of Value Sales
for Stroke, Traumatic Brain Injury, Spinal Cord Injury,
Parkinsons, Cerebral Palsy and Other Applications for the Years
2012, 2020 & 2027
RUSSIA
Table 97: Russia Current & Future Analysis for
Neurorehabilitation Devices by Product - Neurorobotic Systems,
Brain Computer Interfaces, Non-invasive Brain Stimulators and
Wearable Devices - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 98: Russia Historic Review for Neurorehabilitation
Devices by Product - Neurorobotic Systems, Brain Computer
Interfaces, Non-invasive Brain Stimulators and Wearable Devices
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 99: Russia 15-Year Perspective for Neurorehabilitation
Devices by Product - Percentage Breakdown of Value Sales for
Neurorobotic Systems, Brain Computer Interfaces, Non-invasive
Brain Stimulators and Wearable Devices for the Years 2012, 2020 &
2027
Table 100: Russia Current & Future Analysis for
Neurorehabilitation Devices by Application - Stroke, Traumatic
Brain Injury, Spinal Cord Injury, Parkinsons, Cerebral Palsy
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 101: Russia Historic Review for Neurorehabilitation
Devices by Application - Stroke, Traumatic Brain Injury, Spinal
Cord Injury, Parkinsons, Cerebral Palsy and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 102: Russia 15-Year Perspective for Neurorehabilitation
Devices by Application - Percentage Breakdown of Value Sales
for Stroke, Traumatic Brain Injury, Spinal Cord Injury,
Parkinsons, Cerebral Palsy and Other Applications for the Years
2012, 2020 & 2027
REST OF EUROPE
Table 103: Rest of Europe Current & Future Analysis for
Neurorehabilitation Devices by Product - Neurorobotic Systems,
Brain Computer Interfaces, Non-invasive Brain Stimulators and
Wearable Devices - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 104: Rest of Europe Historic Review for
Neurorehabilitation Devices by Product - Neurorobotic Systems,
Brain Computer Interfaces, Non-invasive Brain Stimulators and
Wearable Devices Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 105: Rest of Europe 15-Year Perspective for
Neurorehabilitation Devices by Product - Percentage Breakdown
of Value Sales for Neurorobotic Systems, Brain Computer
Interfaces, Non-invasive Brain Stimulators and Wearable Devices
for the Years 2012, 2020 & 2027
Table 106: Rest of Europe Current & Future Analysis for
Neurorehabilitation Devices by Application - Stroke, Traumatic
Brain Injury, Spinal Cord Injury, Parkinsons, Cerebral Palsy
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 107: Rest of Europe Historic Review for
Neurorehabilitation Devices by Application - Stroke, Traumatic
Brain Injury, Spinal Cord Injury, Parkinsons, Cerebral Palsy
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 108: Rest of Europe 15-Year Perspective for
Neurorehabilitation Devices by Application - Percentage
Breakdown of Value Sales for Stroke, Traumatic Brain Injury,
Spinal Cord Injury, Parkinsons, Cerebral Palsy and Other
Applications for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Table 109: Asia-Pacific Current & Future Analysis for
Neurorehabilitation Devices by Geographic Region - Australia,
India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 110: Asia-Pacific Historic Review for Neurorehabilitation
Devices by Geographic Region - Australia, India, South Korea
and Rest of Asia-Pacific Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 111: Asia-Pacific 15-Year Perspective for
Neurorehabilitation Devices by Geographic Region - Percentage
Breakdown of Value Sales for Australia, India, South Korea and
Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
Table 112: Asia-Pacific Current & Future Analysis for
Neurorehabilitation Devices by Product - Neurorobotic Systems,
Brain Computer Interfaces, Non-invasive Brain Stimulators and
Wearable Devices - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 113: Asia-Pacific Historic Review for Neurorehabilitation
Devices by Product - Neurorobotic Systems, Brain Computer
Interfaces, Non-invasive Brain Stimulators and Wearable Devices
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 114: Asia-Pacific 15-Year Perspective for
Neurorehabilitation Devices by Product - Percentage Breakdown
of Value Sales for Neurorobotic Systems, Brain Computer
Interfaces, Non-invasive Brain Stimulators and Wearable Devices
for the Years 2012, 2020 & 2027
Table 115: Asia-Pacific Current & Future Analysis for
Neurorehabilitation Devices by Application - Stroke, Traumatic
Brain Injury, Spinal Cord Injury, Parkinsons, Cerebral Palsy
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05961066/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001